F Mami-Chouaib, C Blanc, S Corgnac, S Hans… - … for immunotherapy of …, 2018 - Springer
CD8+ T lymphocytes are the major anti-tumor effector cells. Most cancer immunotherapeutic
approaches seek to amplify cytotoxic T lymphocytes (CTL) specific to malignant cells. A …